Gelin Catherine, Sloma Ivan, Charron Dominique, Mooney Nuala
INSERM, U662, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France.
J Leukoc Biol. 2009 Feb;85(2):215-24. doi: 10.1189/jlb.0308206. Epub 2008 Sep 22.
MHC class II and CD1-mediated antigen presentation on various APCs [B cells, monocytes, and dendritic cells (DC)] are subject to at least three distinct levels of regulation. The first one concerns the expression and structure of the antigen-presenting molecules; the second is based on the extracellular environment and signals of danger detected. However, a third level of regulation, which has been largely overlooked, is determined by lateral associations between antigen-presenting molecules and other proteins, their localization in specialized microdomains within the plasma membrane, and their trafficking pathways. This review focuses on features common to MHC II and CD1 molecules in their ability to activate specific T lymphocytes with the objective of addressing one basic question: What are the mechanisms regulating antigen presentation by MHC II and CD1 molecules within the same cell? Recent studies in immature DC, where MHC II and CD1 are coexpressed, suggest that the invariant chain (Ii) regulates antigen presentation by either protein. Ii could therefore favor MHC II or CD1 antigen presentation and thereby discriminate between antigens.
主要组织相容性复合体(MHC)II类分子和CD1介导的各种抗原呈递细胞(B细胞、单核细胞和树突状细胞)上的抗原呈递至少受到三个不同水平的调控。第一个涉及抗原呈递分子的表达和结构;第二个基于细胞外环境和检测到的危险信号。然而,第三个很大程度上被忽视的调控水平,由抗原呈递分子与其他蛋白质之间的侧向关联、它们在质膜内特殊微结构域中的定位以及它们的运输途径所决定。本综述聚焦于MHC II类分子和CD1分子在激活特定T淋巴细胞能力方面的共同特征,目的是解决一个基本问题:在同一细胞内,调控MHC II类分子和CD1分子抗原呈递的机制是什么?最近在未成熟树突状细胞中的研究表明,MHC II类分子和CD1分子共表达,恒定链(Ii)通过这两种蛋白质调控抗原呈递。因此,Ii可能有利于MHC II类分子或CD1分子的抗原呈递,从而区分不同抗原。